Fresenius Medical Company Insiders

FMS Stock  USD 20.93  0.44  2.06%   
Fresenius Medical employs about 113.6 K people. The company is managed by 32 executives with a total tenure of roughly 150 years, averaging almost 4.0 years of service per executive, having 3551.22 employees per reported executive. Breaking down Fresenius Medical's management performance can provide insight into the firm performance.
Kent Wanzek  CEO
Member of the Management Board - Fresenius Medical Care Management AG and CEO of Global Manufacturing and Quality - Fresenius Medical Care Management AG
Katarzyna MazurHofsaess  CEO
Member of the Management Board, Chief Executive Officer for Europe, Middle East and Africa (EMEA) Segment
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fresenius Medical Care. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Fresenius Medical's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Fresenius Medical's future performance. Based on our forecasts, it is anticipated that Fresenius will maintain a workforce of slightly above 113640 employees by November 2024.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

Fresenius Medical Management Team Effectiveness

The company has Return on Asset of 0.029 % which means that on every $100 spent on assets, it made $0.029 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0506 %, implying that it generated $0.0506 on every 100 dollars invested. Fresenius Medical's management efficiency ratios could be used to measure how well Fresenius Medical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is likely to gain to 0.07 in 2024, whereas Return On Tangible Assets are likely to drop 0.03 in 2024. At this time, Fresenius Medical's Other Current Assets are comparatively stable compared to the past year. Intangible Assets is likely to gain to about 1.7 B in 2024, whereas Non Current Assets Total are likely to drop slightly above 13.8 B in 2024.
Common Stock Shares Outstanding is likely to gain to about 405.8 M in 2024. Net Income Applicable To Common Shares is likely to gain to about 931.7 M in 2024

Fresenius Medical Workforce Comparison

Fresenius Medical Care is one of the top stocks in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 748,018. Fresenius Medical retains roughly 113,639 in number of employees claiming about 15% of equities under Health Care industry.

Fresenius Medical Profit Margins

The company has Net Profit Margin of 0.03 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.08 %, which entails that for every 100 dollars of revenue, it generated $0.08 of operating income.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.360.2532
Significantly Up
Slightly volatile
Net Profit Margin0.04560.0257
Way Up
Slightly volatile
Pretax Profit Margin0.080.0468
Way Up
Slightly volatile
Return On Assets0.0140.0147
Notably Down
Slightly volatile
Return On Equity0.07270.0366
Way Up
Slightly volatile

Fresenius Medical Care Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Fresenius Medical Care Price Series Summation is a cross summation of Fresenius Medical price series and its benchmark/peer.

Fresenius Medical Notable Stakeholders

A Fresenius Medical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Fresenius Medical often face trade-offs trying to please all of them. Fresenius Medical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Fresenius Medical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
FACHE MBACEO BoardProfile
Kent WanzekMember of the Management Board - Fresenius Medical Care Management AG and CEO of Global Manufacturing and Quality - Fresenius Medical Care Management AGProfile
Katarzyna MazurHofsaessMember of the Management Board, Chief Executive Officer for Europe, Middle East and Africa (EMEA) SegmentProfile
Olaf SchermeierCEO of Global RandD at Fresenius Medical Care Management AG and Member of the Management Board at Fresenius Medical Care Management AGProfile
William ValleMember of the Management Board, Chief Executive Officer for the North America SegmentProfile
Harry WitMember of the Management Board, Chief Executive Officer for the Asia-Pacific SegmentProfile
Dieter SchenkVice Chairman of the Supervisory BoardProfile
Rolf ClassonIndependent Vice Chairman of the Supervisory BoardProfile
Ben LippsHonorary ChairmanProfile
Rice PowellChairman of the Management Board, Chief Executive OfficerProfile
Oliver MaierSenior Vice President of Investor RelationsProfile
Martin FischerCFO BoardProfile
Helen GizaChief Financial Officer, Member of the Management Board, Chief Transformation OfficerProfile
Roberto FusteMember of the Management Board for Asia-PacificProfile
Pascale WitzIndependent Member of the Supervisory BoardProfile
GailSuzanne BrownSenior DevelopmentProfile
Katarzyna MazurHofsabManagement AGProfile
Borries MullerSenior CommunicationsProfile
Joachim WeithSenior AffairsProfile
Robert PowellChairman BoardProfile
Franklin FACPGlobal BoardProfile
Gregory SorensenIndependent Member of the Supervisory BoardProfile
Dorothea WenzelIndependent Member of the Supervisory BoardProfile
Glenn SlaterSenior OperationsProfile
Gregor ZuendIndependent Member of the Supervisory BoardProfile
Nwamaka MDHead OperationsProfile
William JohnstonIndependent Member of the Supervisory BoardProfile
Dominik HegerHead of Investor Relations & Corporate CommunicationsProfile
Frank MadduxMember of the Management Board, Global Chief Medical OfficerProfile
Jorg HaringCompliance LegalProfile
Wolfgang KummerleSenior InternationalProfile
Carla KriwetCEO CareProfile

About Fresenius Medical Management Performance

The success or failure of an entity such as Fresenius Medical Care often depends on how effective the management is. Fresenius Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Fresenius management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Fresenius management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.03  0.03 
Return On Capital Employed 0.05  0.05 
Return On Assets 0.01  0.01 
Return On Equity 0.04  0.07 
Please note, the imprecision that can be found in Fresenius Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Fresenius Medical Care. Check Fresenius Medical's Beneish M Score to see the likelihood of Fresenius Medical's management manipulating its earnings.

Fresenius Medical Workforce Analysis

Traditionally, organizations such as Fresenius Medical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Fresenius Medical within its industry.

Fresenius Medical Manpower Efficiency

Return on Fresenius Medical Manpower

Revenue Per Employee171.2K
Revenue Per Executive607.9M
Net Income Per Employee4.4K
Net Income Per Executive15.6M
Working Capital Per Employee22.8K
Working Capital Per Executive80.9M

Additional Tools for Fresenius Stock Analysis

When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.